TellWell
…
← Misinformation tracker
FalseNews · Health

Mostly True but Misleading: FDA Approves Mifepristone Through 70 Days — Which Is Exactly 10 Weeks

“FDA recommendations specify that mifepristone pills should only be used up to 10 weeks of gestation”

The argument in brief

The claim says FDA recommendations limit mifepristone to 10 weeks of gestation. That figure is essentially correct, but the precise FDA language is '70 days of gestation' — and the distinction matters because the original 2000 approval was only 49 days. The 10-week limit has been in place since a 2016 update, so the claim is accurate in substance but can obscure important history and precision.

The numbersFDA-Approved Gestational Limit for Mifepristone Over Time

Data: FDA Mifeprex Label History

Why it spread

Abortion medication is one of the most politically contested topics in the U.S., and people on all sides sometimes simplify or slightly misstate FDA rules — opponents to imply the drug is used recklessly outside approved limits, and supporters to assert clear legal access. The '10 weeks' shorthand is close enough to the truth that it circulates widely without triggering correction, even though the precise regulatory language and the history behind it tell a more complete story.

The claim states that FDA recommendations specify mifepristone should only be used up to 10 weeks of gestation. This is largely correct — but the precise FDA language is '70 days of gestation,' which equals exactly 10 weeks. The difference is small but worth understanding clearly.

The FDA-approved label for Mifeprex, updated most recently in 2023, states the drug is approved for use 'through 70 days gestation,' paired with misoprostol. The Guttmacher Institute and the American College of Obstetricians and Gynecologists (ACOG) both confirm this 70-day threshold in their own guidance documents. ACOG's practice bulletin is literally titled 'Medication Abortion Up to 70 Days of Gestation.'

Why does the exact wording matter? Because the original FDA approval in 2000 set the limit at just 49 days — seven weeks. The 2016 update extended that to 70 days. Saying '10 weeks' without that context can make it sound like the current limit has always existed, or obscure the fact that access was significantly more restricted for 16 years.

It is also worth noting that ACOG points out evidence supports use of mifepristone beyond 70 days in some circumstances — but that would be off-label use, outside the FDA's formal approval. The approved window remains 70 days.

This kind of near-accurate claim spreads easily because it is close enough to the truth to pass casual fact-checking. In a politically charged debate like abortion access, even small imprecisions get amplified — sometimes to suggest the drug is being misused, sometimes to defend access rights. The safest habit is to check the actual FDA label, which is publicly available and straightforward to read.

Sources

  • FDA Drug Label for Mifeprex (Mifepristone) - 2023

    The FDA-approved label for Mifeprex specifies use through 70 days (10 weeks) of gestation, not 'up to 10 weeks.' The label was updated in 2023 and the approved regimen is mifepristone 200mg followed by misoprostol, used through 70 days gestation.

  • FDA Mifeprex REMS Program Information

    FDA specifies the approved use is through 70 days (10 weeks, i.e., up to and including day 70) of gestation. The claim of '10 weeks' is directionally correct but the precise FDA language is '70 days gestation,' which equals exactly 10 weeks — making the claim technically accurate in substance but potentially misleading in precision.

  • Guttmacher Institute - Medication Abortion

    Guttmacher confirms the FDA-approved regimen for mifepristone is through 70 days (10 weeks) of pregnancy, consistent with FDA labeling updated in 2016 from the original 49-day limit.

  • ACOG Practice Bulletin on Medication Abortion

    ACOG's practice bulletin is titled 'Medication Abortion Up to 70 Days of Gestation,' confirming the 70-day (10-week) threshold. ACOG notes that evidence supports use beyond this window off-label, but FDA approval is through 70 days.

TellWell AI

Related debunks